STAT

Opinion: The health information exchange has evolved from hunter and gatherer to cultivator

"I don't want more data," the chief medical officer of a large health system told me. "We are already drowning in it."
Source: RODGER BOSCH/AFP via Getty Images

“Data is the new oil,” British data scientist Clive Humby once said. “It’s valuable, but if unrefined it cannot really be used.”

I thought about that line recently when I met with the chief medical officer of a large health system. “I don’t want more data,” she told me, “we are already drowning in it.”

Across the nation, we are making progress in exchanging health data. But if it isn’t refined and turned into insight, it does no one any good. That’s why health information exchanges (HIEs) — platforms that help coordinate care by allowing data sharing among various provider organizations and health plans — are stepping into a new,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks